IP Library Granted Patent US 9,720,253
Granted Patent B2
US 9,720,253 · App. 13/141,161 · Granted Aug 1, 2017

Method and apparatus for limiting growth of eye length

Inventors: Jay Neitz (Seattle, WA); Maureen Neitz (Seattle, WA)
Assignee: THE MEDICAL COLLEGE OF WISCONSIN
G02C7/04A61K9/0048G02C7/02G02C7/061G02C7/10A61B3/1005A61B5/107G02C2202/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,720,253
App. No.
13/141,161
Granted
Aug 1, 2017
Kind
B2
Abstract

Certain embodiments of the present invention are directed to therapeutic intervention in patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the eye-length-related disorders. Embodiments of the present invention include methods for early recognition of patients with eye-length-related disorders, therapeutic methods for inhibiting further degradation of vision in patients with eye-length-eye-length-related disorders, reversing, when possible, eye-length-related disorders, and preventing eye-length-related disorders. Additional embodiments of the present invention are directed to particular devices used in therapeutic intervention in patients with eye-length-related disorders.

Claims (15)

1. A therapeutic device for preventing, ameliorating, or reversing eye-length-related disorders, the therapeutic device comprising one of:

blur-inducing glasses;

blur-inducing contact lenses;

blur-inducing glasses that incorporate wavelength-dependent filters;

blur-inducing contact lenses that incorporate wavelength-dependent filters;

glasses that incorporate wavelength-dependent filters; and

contact lenses that incorporate wavelength-dependent filters;

wherein blur-inducing glasses are configured to induce blurring by one or more of:

bumps or depressions in one or both surfaces of lenses of said glasses;

inclusions within the lenses of said glasses of a material different from a material of said lenses;

configuring the lenses of said glasses to have higher-level aberrations including higher-level aberrations that preferentially affect peripheral vision when said device is worn;

providing progressive negative corrections to optical power of one or both lenses, of said blur-inducing glasses, from top to bottom of said one or both lenses;

coatings or films applied to one or both surfaces of the lenses of said glasses;

wherein a first lens of said device has a first central, non-blur-inducing region and a second lend lens of said device has a second central, minimal-blur inducing region; and

wherein said bumps, depressions, inclusions, coatings, and films are configured to increase a level of blurring from said first central, non-blur-inducing region of the first lens of said blur-inducing glasses outward.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 4, 2018
From: MEDICAL COLLEGE OF WISCONSIN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 047714/0081 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2011
From: NEITZ, JAY; NEITZ, MAUREEN
To: THE MEDICAL COLLEGE OF WISCONSIN
Reel/Frame 026886/0015 →
Continuity (2)
Provisional Application 61139938 · Dec 22, 2008
Related Publication 20110313058A1 · Dec 22, 2011